Role of glutathione peroxidase 1 in breast cancer: Loss of heterozygosity and allelic differences in the response to selenium

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3347-3351

  Hu, Ya Jun ^a   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; LEUCINE; PROLINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CARCINOMA CELL; CODON; CONCENTRATION RESPONSE; DNA DETERMINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

ADENOCARCINOMA; ALANINE; ALLELES; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CODON; DNA, NEOPLASM; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE PEROXIDASE; LEUCINE; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROLINE; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SELENIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0038068938     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. El-Bayoumy, K. (ed.). The Role of Selenium in Cancer Prevention. pp. 1-15. Philadelphia: Lippincolt. 1991.
2. Ip, C. Selenium and experimental cancer. Ann. Clin. Res., 18: 22-29, 1986.
3. Yu, S. Y., Zhu, Y. J., and Li, W. G. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol. Trace Elem. Res., 56: 117-124, 1997.
4. Clark, L. C., Combs, G. F. J., Tumbull, B. W., Slate, E. H., Chalker, E. H., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L. J., Park, H. K., Sanders, B. B. J., Smith, C. L., and Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J. Am. Med. Assoc., 276: 1957-1963, 1996.
5. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B., and Giovannucci, E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl. Cancer Inst. (Bethesda). 90: 1219-1224, 1998.
6. Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., Nelson, W. G., Muller, D., Andres, R., and Carter, H. B. Plasma selenium level before diagnosis and the risk of prostate cancer development. J. Urol., 166: 2034-2038, 2001.
7. Knekt, P., Marniemi, J. Teppo, L. Heliovaara, M., and Aromaa, A. Is low selenium status a risk factor for lung cancer? Am. J. Epidemiol., 148: 975-982, 1998.
8. McConnell, K. P., Jager, R. M. Bland, K. I., and Blotcky, A. J. The relationship of dietary selenium and breast cancer. J. Surg. Oncol., 15: 67-70, 1980.
9. Garland, M. Morris, J. S., Stampfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K. Rosner, B., Speizer, F. E., Willetl, W. C., and Hunter, D. J. Prospective study of toenail selenium levels and cancer among women. J. Natl. Cancer Inst. (Bethesda), 87: 497-505, 1995.
10. Garland, M., Willett, W. C. Manson, J. E., and Hunter, D. J. Antioxidant micronutrients and breast cancer. J. Am. Coll. Nutr., 12: 400-411, 1993.
11. Hunter, D. J., Morris, J. S., Stampfer, M. J., Colditz, G. A., Speizer, F. E., and Willett, W. C. A prospective study of selenium status and breast cancer risk. J. Am. Med. Assoc., 264: 1128-1131, 1990.
12. Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D., and Lacroix, A. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect. Prev., 24: 305-313, 2000.
13. Arthur, J. R. The glutathione peroxidases. Cell. Mol. Life Sci., 57: 1825-1835, 2000.
14. Cheng, W. H., He, Y. S., Valentine, B. A., Ross, D. A., Combs, G. F., Jr., and Lei, X. G. Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J. Nutr. 128: 1070-1076, 1998.
15. Moscow, J. A., Schmidt, L., Ingram, D. T., Gnarra, J., Johnson, B., and Cowan, K. H. Loss of heterozygosity of the human cytosolic glutathione peroxidase 1 gene in lung cancer. Carcinogenesis (Lond.), 15: 2769-2773, 1994.
16. Hardie, L. J., Briggs, J. A., Davidson, L. A., Allan, J. M., King, R. F., Williams, G. I., and Wild, C. P. The effect of hOOG1 and glutathione peroxidase 1 genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis (Lond.), 21: 167-172, 2000.
17. Ratnasinghe, D., Tangrea, J. A., Andersen, M. R., Barrett, M. J., Virtamo, J., Taylor, P. R., and Albanes, D. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res., 60: 6381-6383, 2000.
18. Hu, Y. J., Korotkov, K. V., Mehta, R., Hatfield, D. L., Rotimi, C. N., Luke, A., Prewitt, T. E., Cooper, R. S., Slock, W., Vokes, E. E., Dolan, M. E., Gladyshev, V. N., and Diamond, A. M. Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res., 61: 2307-2310, 2001.
19. Ishida, K., Morino, T., Takagi, K., and Sukenaga, Y. Nucleotide sequence of a human gene for glutathione peroxidase. Nucleic Acids Res., 15: 10051, 1987.
20. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
21. Samuels, B. L., Murray, J. L., Cohen, M. B., Safa, A. R., Sinha, B. K., Townsend, A. J., Beckett, M. A., and Weichselbaum, R. R. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res., 51: 521-527, 1991.
22. Mansur, D. B., Kataoka, Y., Grdina, D. J., and Diamond, A. M. Radiosensitivity of mammalian cell lines engineered to overexpress cytosolic glutathione peroxidase. Radiat. Res., 155: 536-542, 2001.
23. Berry, M. J., Banu, L., Harney, J. W., and Larsen, P. R. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J., 12: 3315-3322, 1993.
24. Forsberg, L., de Faire, U., Marklund, S. L., Andersson, P. M., Stegmayr, B., and Morgenslern, R. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol. Dis., 26: 423-426, 2000.
25. Martinez, A., Walker, R., and Shan, J. Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol. Pathol. 54: 300-306, 2001.
26. Maitra, A. W. I., Washington, C., Virmani, A. K., Ashfaq, R., Milchgrub, S., Gazdar, A. F., and Minna, J. D. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern or allele loss. Am. J. Pathol., 159: 119-130, 2001.
27. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350: 1047-1059, 1997.
28. Russo, J., Hu, Y. F. T. Q., Mihaila, D., Slater, C., Lareef, M. H., and Russo, I. H. Carcinogenicity of estrogens in human breast epithelial cells. Acta Pathol. Microbiol. Immunol. Scand., 109: 39-52, 2001.
29. Mitsudomi, T. O. T., Nishida, K., Ogami, A., Osaki, T., Sugio, K., Yasumoto, K., Sugimachi, K., and Gazdar, A. F. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin. Cancer Res., 2: 1185-1189, 1996.